Provided by Tiger Trade Technology Pte. Ltd.

MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF

30.10
-0.0934-0.31%
Volume:85
Turnover:3K
Market Cap:21.67M
PE:- -
High:30.10
Open:30.19
Low:30.10
Close:30.19
52wk High:32.57
52wk Low:24.64
Shares:720.00K
Float Shares:720.00K
Volume Ratio:0.27
T/O Rate:0.01%
Dividend:0.72
Dividend Rate:2.38%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Legend Biotech Launches Inaugural Elite Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

THOMSON REUTERS
·
11 mins ago

Legend Biotech Says Five-Year Carvykti Data Show 50% of Patients Remained Progression-Free and Alive

MT Newswires Live
·
Sep 25

Legend Biotech Reports Five-Year CARVYKTI Survival Data in Earlier-Line Myeloma

TIPRANKS
·
Sep 25

Legend Biotech Shareholders Back Board Slate and Expand Equity Plan at 2026 AGM

TIPRANKS
·
Sep 25

Legend Biotech Shareholders Voted at Annual General Meeting

Reuters
·
Sep 25

Legend Biotech CFO Makes a Notable Move With Fresh Insider Stock Sale

TIPRANKS
·
Sep 24

UTStarcom Unveils Optical Circuit Switching (OCS) Solution for AI Data Centers at CIOE 2026

GlobeNewswire
·
Sep 21

Legend Biotech CEO Ingrid Zhang Files Initial Beneficial Ownership Statement

Reuters
·
Sep 17

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
Sep 16

Legend Biotech Shares Down 1.8%; Co Appoints Ingrid Zhang as CEO

THOMSON REUTERS
·
Sep 15

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

Legend Biotech Corporation - Alan Bash to Resume Role as President, Carvykti

THOMSON REUTERS
·
Sep 15

Legend Biotech Corporation - Appoints Ingrid Zhang as CEO Effective September 15, 2026

THOMSON REUTERS
·
Sep 15

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Sep 15

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Sep 15

Two Ministries Unveil 30 Trillion Yuan Plan to Supercharge Electronics Manufacturing

Deep News
·
Sep 15

Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline

TIPRANKS
·
Sep 14

Legend Biotech : Barclays Cuts Target Price to $74 from $78

THOMSON REUTERS
·
Sep 11

GenScript Unit Legend Biotech to Present Updated Long-Term Carvykti Cartitude-2 Data at IMS Meeting

Reuters
·
Sep 10

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 01